US · GEG
Great Elm Group, Inc.
- Sector
- Healthcare · Medical - Distribution
- Headquarters
- Waltham, MA 02453
- Website
- greatelmgroup.com
Price · as of 2025-06-30
$2.05
Market cap 56.61M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $83.40 | +3,968.29% |
| Intrinsic Value(DCF) | $2.34 | +14.15% |
| Graham-Dodd Method(GD) | $4.86 | +137.07% |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $22.08 | $20.55 | $0.98 | $0.00 | $19.00 |
| 2012 | $21.48 | $14.28 | $6.46 | $17.67 | $0.00 |
| 2013 | $21.72 | $13.92 | $0.02 | $0.00 | $490.34 |
| 2014 | $24.72 | $4,644.19 | $423.43 | $6.51 | $1,239.76 |
| 2015 | $9.36 | $1,366.04 | $0.00 | $0.00 | $338.56 |
| 2016 | $4.79 | $30.37 | |||
| 2017 | $3.35 | $2.51 | $0.00 | ||
| 2018 | $3.00 | $26.54 | $1.96 | $0.37 | $0.00 |
| 2019 | $3.63 | $126.60 | $1,461.60 | $0.00 | $0.00 |
| 2020 | $2.25 | $39.68 | $1,835.08 | $0.00 | $0.00 |
| 2021 | $2.25 | $100.90 | $669.56 | $0.00 | $0.00 |
| 2022 | $2.05 | $106.51 | $0.74 | $0.00 | $44.73 |
| 2023 | $2.13 | $113.15 | $1.70 | $7.00 | $92.02 |
| 2024 | $1.87 | $62.06 | $383.97 | $1.86 | $0.00 |
| 2025 | $2.75 | $83.40 | $31.22 | $4.86 | $0.00 |
AI valuation
Our deep-learning model estimates Great Elm Group, Inc.'s (GEG) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $83.40
- Current price
- $2.05
- AI upside
- +3,968.29%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$2.34
+14.15% upside
Graham-Dodd
$4.86
+137.07% upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| GEG | Great Elm Group, Inc. | $2.05 | 56.61M | +3,968% | +14% | +137% | — | 4.89 | 1.08 | 4.66 | 1.39 | — | 1.31 | -0.66% | -49.05% | 79.01% | 23.38% | -51.59% | 10.56% | 0.89 | -1.93 | 14.34 | 11.85 | 1.33 | -81274.00% | -851.00% | -4210.00% | -11.85% | -0.94 | -58.38% | 0.00% | 0.00% | 9.52% | -3.64 | -3.24 | 1.79 | -27.91 |
| ACET | Adicet Bio, Inc. | $7.25 | 69.44M | — | — | — | — | -0.60 | 0.37 | — | 0.81 | — | 0.37 | 0.00% | — | — | -65.65% | -433.12% | -54.79% | 0.09 | -31903.75 | 9.29 | 9.09 | 0.35 | -5982.00% | — | -477.00% | -133.68% | -4.76 | -317.32% | 0.00% | 0.00% | 0.00% | 0.70 | 0.95 | — | -2.95 |
| ASRT | Assertio Holdings, Inc. | $11.66 | 74.82M | +1,017% | +6,046% | -82% | +159% | -3.44 | 0.61 | 0.59 | 2.82 | — | 1.83 | 68.61% | -19.59% | -17.27% | -16.66% | -29.57% | -7.56% | 0.33 | -8.05 | 1.77 | 1.34 | -2.01 | -9507.00% | -1783.00% | -4608.00% | 35.54% | 0.23 | 31.91% | 0.00% | 0.00% | 0.47% | -0.59 | 0.55 | 0.12 | -2.51 |
| EDAP | Edap Tms S.a. | $4.37 | 163.4M | +598% | -76% | — | — | -4.26 | 1.98 | 1.26 | -4.08 | — | 2.16 | 41.42% | -32.03% | -29.66% | -38.88% | -87.65% | -21.42% | 0.34 | -87.01 | 1.85 | 1.33 | 1.00 | -1053.00% | 611.00% | -679.00% | -21.85% | -0.36 | -75.49% | 0.00% | 0.00% | 0.00% | -3.17 | -3.68 | 1.01 | 0.14 |
| FORA | Forian Inc. | $2.08 | 64.63M | +2,189% | +1,760% | -83% | — | -17.38 | 2.18 | 3.25 | -12.78 | — | 2.27 | 63.61% | -34.67% | -18.71% | -13.05% | -342.94% | -6.98% | 0.22 | -9.86 | 2.68 | 2.51 | -0.73 | -13333.00% | -160.00% | -5671.00% | 0.43% | 0.02 | 13.88% | 0.00% | 0.00% | 23.07% | -5.32 | 131.52 | 1.85 | 1.46 |
| IMUX | Immunic, Inc. | $1.02 | 100.66M | — | — | — | — | -16.98 | -247.31 | — | -16.85 | — | -247.31 | 0.00% | — | — | -1653.15% | 539.27% | -299.36% | -0.02 | — | 0.75 | 0.64 | 0.16 | -3800.00% | — | 110.00% | -5.21% | -2.80 | 449.10% | 0.00% | 0.00% | 0.00% | -15.84 | -19.02 | — | -17.75 |
| LITS | Lite Strategy, Inc. | $1.13 | 41.55M | +12,712% | — | — | — | -1.77 | 1.66 | — | -0.60 | — | 1.66 | 0.00% | — | — | -63.84% | 545.04% | -53.45% | 0.00 | — | 13.50 | 13.30 | 1.05 | -18951.00% | -10000.00% | -5871.00% | -73.96% | -15.39 | 650.87% | 0.00% | 0.00% | 50.76% | -0.58 | -0.49 | — | -20.49 |
| LUNG | Pulmonx Corporation | $1.58 | 65.17M | +1,684% | +90% | — | — | -5.19 | 3.41 | 3.49 | -4.87 | — | 3.50 | 74.00% | -68.87% | -67.30% | -55.25% | -138.32% | -33.11% | 0.66 | -16.45 | 5.58 | 4.72 | 0.28 | -1000.00% | 2201.00% | -1414.00% | -11.27% | -1.29 | -79.07% | 0.00% | 0.00% | 0.00% | -4.29 | -7.50 | 2.95 | -1.57 |
| NTRB | Nutriband Inc. | $4.44 | 54.06M | +340% | -57% | — | — | -4.78 | 7.79 | 23.39 | -4.51 | -10.98 | 11.26 | 32.68% | -312.62% | -489.86% | -162.94% | -157.60% | -139.89% | 0.03 | -312.51 | 4.88 | 4.46 | 0.41 | 4348.00% | 262.00% | 3184.00% | -9.43% | -4.71 | -111.17% | 0.00% | 0.00% | 8.03% | -6.87 | -9.73 | 21.47 | 19.59 |
| TCRX | TScan Therapeutics, Inc. | $1.06 | 60.15M | +2,649% | +18% | — | +7,924% | -1.74 | 0.92 | 78.74 | -0.24 | — | 0.92 | 100.00% | -4787.68% | -4527.66% | -65.08% | -271.01% | -39.64% | 0.40 | -36.91 | 8.14 | 8.07 | 0.68 | -1618.00% | -8662.00% | 7774.00% | -51.70% | -3.08 | -230.45% | 0.00% | 0.00% | 18.21% | -0.22 | -0.25 | 10.30 | -0.75 |
| XBIT | XBiotech Inc. | $2.26 | 68.9M | — | — | — | — | -2.57 | 0.54 | — | 1.76 | -4.62 | 0.54 | 0.00% | — | — | -19.21% | -219.51% | -18.10% | 0.06 | -52.63 | 11.56 | 11.49 | 4.51 | 5556.00% | — | 6905.00% | -32.59% | -2.05 | -166.91% | 0.00% | 0.00% | 0.00% | 1.49 | 1.97 | — | 3.15 |
About Great Elm Group, Inc.
Great Elm Group, Inc. engages in the durable medical equipment and investment management businesses. The company distributes respiratory care equipment, including positive air pressure equipment and supplies, ventilators and oxygen equipment, and replacement parts, as well as provides sleep study services; and rents medical equipment. It also offers investment management services. The company was formerly known as Great Elm Capital Group, Inc. and changed its name to Great Elm Group, Inc. in December 2020. Great Elm Group, Inc. was founded in 1994 and is headquartered in Waltham, Massachusetts.
- CEO
- Jason W. Reese
- Employees
- 31
- Beta
- 0.44
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($2.34 ÷ $2.05) − 1 = +14.15% (DCF, example).